US FDA approves Centinel Spine's 3 additional prodisc cervical total disc replacement devices

Centinel Spine, LLC, a leading global medical device company, announced US Food and Drug Administration (FDA) Pre-Market Application (PMA) approval for 1-level indications for three additional cervical total disc replacement (TDR) devices...

Bayer to sell testosterone drug for up to 500 mn euros

German chemicals giant Bayer said it was selling its male testosterone replacement drug Nebido for up to half-a-billion euros in order to concentrate on medical innovation...

Jubilant Pharma to raise USD 400 million loan from Standard Chartered Bank to repay debt

Jubilant Pharma Holdings said it has signed an agreement with Standard Chartered Bank for a five-year loan of USD 400 million, about Rs 3,186 crore. Majority of the amount will be used for repayment of existing term loan and debt bonds, the firm...

Bajaj Healthcare forays into opiate processing industry

Bajaj Healthcare said it has forayed into the highly regulated opiate processing business...

Serum Institute to launch indigenously made vaccine to treat cervical cancer

Serum Institute of India CEO Adar Poonawalla on Tuesday said the company plans to launch its indigenously-developed vaccine to treat cervical cancer in women later this year...

NTAGI to discuss data of Gennova pharmaceuticals' indigenous mRNA vaccine

The National Technical Advisory Group on Immunisation (NTAGI's) Covid working group is expected to conduct a meeting soon to discuss India's first mRNA vaccine against COVID and Biological E's Corbevax Booster dose for Covishield and Covaxin...

Zydus gets FDA approval for type 2 diabetes drug

The US health authorities gave final approval to Zydus Lifesciences, Ahmedabad-based pharmaceutical company to market its generic version of Empagliflozin and Metformin Hydrochloride tablets, which are intended to lower blood sugar levels in pe

Aurobindo Pharma on track to manufacture complex products, expand global footprint

Aurobindo Pharma remains focussed on developing complex and differentiated products in multiple areas comprising oncology, hormonal products, biosimilars, depot injections and vaccines to drive the next phase of growth, as per its Annual Report...

Three Disruptive Innovations to Revolutionize Herbal Medicine Industry

In this article, we have listed the top three positive developments in the traditional and herbal medicine segment that will create a long lasting impact.

How AI can be utilized in the generic drug industry

How Artificial Intelligence can be used to leveraged by Generic drug companies for finding drug biosimilars, researching drug companies crystal structures, and salt & polymorph screening.

© 2025 India Pharma Outlook. All Rights Reserved.